The drugs are thus irreversible DNMT inhibitors, but their lack of selectivity between DNMT isoforms may be one reason for the high toxicity observed in settings other than myelodysplastic syndrome. The gene discussed is DNMT1; the disease is myelodysplastic syndrome.